MS
Martin Javier San
Chief Medical Officer

Martin Javier San insider trades: LeonaBio (LONA) stock sales

Chief Medical Officer, LeonaBio Last trade Mar 4, 2026 14 Form 4 filings
$21K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2020
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Martin reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 4, 2026LONA↓ Sell$9K
Jan 2, 2026ATHA↓ Sell$11K
Jul 1, 2025ATHA↓ Sell$3K
Jan 2, 2025ATHA↓ Sell$6K
Jan 5, 2024ARWR↓ Sell$293K
Nov 20, 2023ARWR↓ Sell$567K
Nov 21, 2022ARWR↓ Sell$585K
Nov 19, 2021ARWR↓ Sell$1.4M
Nov 19, 2020ARWR↓ Sell$1.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LONA insiders

Open-market trades in the last 12 months

About Martin Javier San's insider trades

Martin Javier San is Chief Medical Officer at LeonaBio (LONA). Since Nov 19, 2020, Martin has reported no open-market purchases and 9 sales worth $4.2M on SEC Form 4. In the last 12 months: 2 sales ($21K).

Their filings also include grants and awards (6 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LONA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.